SCHEMBL28224749

SCHEMBL28224749

O=Nc1ccccc1-c1ccccc1N=O

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 5/20 0.40
KMT2A Q03164 5/20 0.40
CDC25B P30305 2/20 0.40
NPC1 O15118 5/20 0.38
MAPT P10636 4/20 0.38
RAB9A P51151 4/20 0.38
SMN1; SMN2 Q16637 4/20 0.38
MAPK1 P28482 3/20 0.38
LMNA P02545 3/20 0.38
POLB P06746 3/20 0.38
HTT P42858 3/20 0.38
MAOA P21397 2/20 0.38
KDM4E B2RXH2 2/20 0.38
APAF1 O14727 2/20 0.38
TDP2 O95551 2/20 0.38
S100A4 P26447 2/20 0.38
CES2 O00748 1/20 0.38
TERT O14746 1/20 0.38
PLIN1 O60240 1/20 0.38
S1PR4 O95977 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22570666 0.85 NPC1 (0.41) MEN1KMT2ANPC1MAPTRAB9A
SCHEMBL18589736 0.85 ALDH1A1 (0.44) MEN1KMT2ANPC1MAPTRAB9A
SCHEMBL3204184 0.85 ALDH1A1 (0.59) NPC1RAB9ASMN1; SMN2MAOAKDM4E
SCHEMBL29690092 0.84 CASP3 (0.48) NPC1MAPTRAB9AMAPK1TDP1
SCHEMBL2010849 0.84 CASP3 (0.48) NPC1MAPTRAB9AMAPK1TDP1
SCHEMBL234460 0.83 NPC1 (0.38) MEN1KMT2ACDC25BNPC1MAPT
SCHEMBL30307825 0.83 NPC1 (0.38) MEN1KMT2ACDC25BNPC1MAPT
Charcoal, Activated SCHEMBL8610664 0.80 NPC1 (0.36) MEN1KMT2ACDC25BNPC1MAPT
SCHEMBL18494509 0.78 AHR (0.38) MAPK1KDM4EALOX15TDP1TSHR
SCHEMBL18619366 0.77 ALDH1A1 (0.44) MEN1KMT2ANPC1MAPTRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-108250034-A A kind of biphenyl compound and its application in 1,3,6- tribromo pyrenes are prepared 李现伟 2018-07-06 CN disclosed